Search research articles
Contact Us
Filters
Showing results (181-190 of 262) with videos related to
Page
of 27
Sort By:
Clinical and Experimental Rheumatology
|
February 12, 2026
Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis
Nantakarn Pongtarakulpanit, Anuradha Bishnoi, Tanya Chandra, et al.
ACR Open Rheumatology
|
September 21, 2022
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
Chester V Oddis, Howard E Rockette, Lei Zhu, et al.
Annals of the Rheumatic Diseases
|
October 11, 2017
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Anna Tjärnlund, Quan Tang, Cecilia Wick, et al.
Rheumatology International
|
July 13, 2024
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study
Alessia Alunno, Francesco Carubbi, Ai Lyn Tan, et al.
Nature Reviews. Rheumatology
|
March 29, 2024
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G S Oldroyd, Jeffrey P Callen, Hector Chinoy, et al.
Nature Reviews. Rheumatology
|
November 9, 2023
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G S Oldroyd, Jeffrey P Callen, Hector Chinoy, et al.
The Journal of Clinical Investigation
|
July 21, 2020
Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathy
Kevin E McElhanon, Nicholas Young, Jeffrey Hampton, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 26, 2025
Anti-Mi2 autoantibodies target the PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily recognize epitopes outside the PHD region of TIF1γ
Iago Pinal-Fernandez, Jon Musai, Maria Casal-Dominguez, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region
Iago Pinal-Fernandez, Jon Musai, Maria Casal-Dominguez, et al.
Journal of Diabetes Investigation
|
September 12, 2023
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
Tulika Chatterjee, Naveen Ravichandran, Narmadha Nair, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 262) with videos related to
Sort By:
Page
of 27
Clinical and Experimental Rheumatology
|
February 12, 2026
Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis
Nantakarn Pongtarakulpanit, Anuradha Bishnoi, Tanya Chandra, et al.
ACR Open Rheumatology
|
September 21, 2022
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
Chester V Oddis, Howard E Rockette, Lei Zhu, et al.
Annals of the Rheumatic Diseases
|
October 11, 2017
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Anna Tjärnlund, Quan Tang, Cecilia Wick, et al.
Rheumatology International
|
July 13, 2024
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study
Alessia Alunno, Francesco Carubbi, Ai Lyn Tan, et al.
Nature Reviews. Rheumatology
|
March 29, 2024
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G S Oldroyd, Jeffrey P Callen, Hector Chinoy, et al.
Nature Reviews. Rheumatology
|
November 9, 2023
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G S Oldroyd, Jeffrey P Callen, Hector Chinoy, et al.
The Journal of Clinical Investigation
|
July 21, 2020
Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathy
Kevin E McElhanon, Nicholas Young, Jeffrey Hampton, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 26, 2025
Anti-Mi2 autoantibodies target the PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily recognize epitopes outside the PHD region of TIF1γ
Iago Pinal-Fernandez, Jon Musai, Maria Casal-Dominguez, et al.
Rheumatology (Oxford, England)
|
August 12, 2025
Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region
Iago Pinal-Fernandez, Jon Musai, Maria Casal-Dominguez, et al.
Journal of Diabetes Investigation
|
September 12, 2023
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
Tulika Chatterjee, Naveen Ravichandran, Narmadha Nair, et al.
Page
of 27